Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
General Catalyst
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2026 Formerly cTRL Therapeutics 2023 (ctrl-therapeutics.com)
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

Harnessing the power of cTRLs. We are harnessing the power of cTRLs – a rare and potent circulating T cell population found in the blood and naturally equipped to fight cancer – to engineer solid tumor cell therapies.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
607 portfolio companies